Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.52 USD | -0.50% | -4.16% | +4.06% |
Mar. 13 | Halozyme Therapeutics Insider Sold Shares Worth $839,100, According to a Recent SEC Filing | MT |
Feb. 21 | Halozyme Therapeutics Q4 Adjusted Earnings, Revenue Rise; Reiterates 2024 Guidance | MT |
Cet article est réservé aux membres
Déjà membre ?
Log InPas encore membre ?
Inscription GratuiteEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.06% | 4.92B | |
-2.40% | 103B | |
+2.18% | 96.56B | |
+1.83% | 22.61B | |
-17.97% | 21.18B | |
-4.50% | 19.07B | |
-41.75% | 16.53B | |
-24.17% | 14.46B | |
+1.94% | 13.25B | |
+21.78% | 11.1B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Halozyme Therapeutics' Q1 Non-GAAP Earnings, Revenue Rise; Issues Full Year 2022 Guidance